← back to search

Francesca Petralia

Authorised Association Consortium · US
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Inflammatory Bowel Disease, Ferroptosis and cancer prognosis, Microscopic Colitis, and Cancer Genomics and Diagnostics.
h-index
35
citations
10,216
works
152
NIH funding
primary concept
Medicine
email

Recent publications

Epstein-Barr Virus Exposure Precedes Crohn's Disease Development
Gastroenterology 2025cited by 15position: middledoi
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Cancer Cell 2025cited by 5position: middledoi
Pan-cancer proteogenomics characterization of tumor immunity
Cell 2024cited by 84position: firstdoi
Comprehensive proteogenomic characterization of rare kidney tumors
Cell Reports Medicine 2024cited by 44position: middledoi
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis
Science Immunology 2024cited by 35position: middledoi
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry
Clinical Gastroenterology and Hepatology 2024cited by 14position: middledoi
Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity
Clinical Gastroenterology and Hepatology 2024cited by 8position: middledoi
Proteogenomic data and resources for pan-cancer analysis
Cancer Cell 2023cited by 216position: middledoi
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Cell 2023cited by 179position: middledoi
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Cancer Cell 2023cited by 100position: middledoi
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cell 2023cited by 99position: middledoi
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Gastroenterology 2023cited by 86position: middledoi
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Cell 2023cited by 86position: middledoi
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Cell Reports Medicine 2023cited by 31position: middledoi
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity
Nature Medicine 2022cited by 231position: middledoi
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell 2022cited by 202position: middledoi
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease
Gastroenterology 2022cited by 61position: middledoi
Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways
Gastroenterology 2022cited by 35position: middledoi
Proteogenomic and metabolomic characterization of human glioblastoma
Cancer Cell 2021cited by 683position: middledoi
A proteogenomic portrait of lung squamous cell carcinoma
Cell 2021cited by 384position: middledoi
Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification
Cancer Cell 2021cited by 347position: middledoi
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms
Gastroenterology 2021cited by 160position: middledoi
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell 2020cited by 810position: middledoi
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Cell 2020cited by 339position: firstdoi
Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
Gastroenterology 2020cited by 233position: middledoi
Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics
Cell Systems 2020cited by 32position: middledoi
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Cell 2019cited by 767position: middledoi
Proteogenomics connects somatic mutations to signalling in breast cancer
Nature 2016cited by 1,748position: middledoi
Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases
Scientific Reports 2015cited by 222position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jean‐Frédéric Colombel · Cornell University3 papers (2022–2024)Joana Torres · University of Lisbon3 papers (2022–2025)Renée M. Laird · Walter Reed Army Institute of Research2 papers (2022–2025)Jordan E. Axelrad · NYU Langone Health1 papers (2024–2024)Kristin E. Burke · Harvard University1 papers (2022–2022) · 1 papers (2024–2024)Steven H. Itzkowitz · Icahn School of Medicine at Mount Sinai1 papers (2024–2024) · 1 papers (2025–2025)Pei Wang · Zhongda Hospital Southeast University1 papers (2025–2025)Cecília M. P. Rodrigues · University of Milan1 papers (2024–2024)Yue Jiang · Nanjing Health and Health Commission1 papers (2024–2024)Joseph A. Murray · Mayo Clinic1 papers (2022–2022)James Richter · University of Minnesota1 papers (2022–2022) · 1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Chad K. Porter · Naval Medical Research Command1 papers (2022–2022)Lea Ann Chen · Northwestern University1 papers (2024–2024)Jean–Frédéric Colombel · University Hospital Medical Center Bezanijska kosa1 papers (2025–2025)Mark Riddle · University of Nevada, Reno1 papers (2025–2025)